Acessibilidade / Reportar erro

Willingness to pay for short- and long-acting contraceptives among female adolescents and their parents in Brazil:a pilot study

ABSTRACT

Objective

To evaluate willingness to pay for short- and long-acting reversible contraceptive methods among female Brazilian adolescents and their parents, as well as their perspective on using such methods.

Methods

This is a cross-sectional study of female adolescents aged 13 to 19 years and their parents. We surveyed to estimate their willingness to pay for contraceptive methods. The values are expressed as mean±standard deviation in Brazilian reals (R$). Spearman correlation was employed for socioeconomic status of parents, age of adolescents and their standpoints. The methods types and adolescent and parent perspectives were analyzed by the test χ2. To determine an agreement between pairs and their willingness to pay, we used the Bland-Altman plot.

Results

A total of 165 surveys were collected. Short-acting method was significantly more acceptable to pay than the long-action method, by both parents and their daughters. Parents and their daughters are willing to pay out-of-pocket R$ 52,25±22,48 and R$ 51,63±21,24 for short-acting reversible contraception method, and R$ 176,83±130,34 and R$ 174,83±143,64, for long-acting method, respectively. Bland-Altman analysis indicated an agreement on both perspectives and the price they are willing to pay for each contraceptive method.

Conclusion

Parents and adolescent daughters are more willing to pay for short-acting methods. We showed an agreement between the parent and the daughter for the values paid for each method.

Long-acting reversible contraception; Contraception; Adolescent; Brazil

RESUMO

Objetivo

Avaliar a disposição de mulheres adolescentes e seus pais a pagar por métodos contraceptivos reversíveis de longa e curta duração, além de suas perspectivas ao usá-los.

Métodos

Este é um estudo transversal com adolescentes de 13 a 19 anos e seus pais. Foi feita uma pesquisa para estimar a disposição a pagar por métodos anticoncepcionais. Os valores estão expressos em média±desvio-padrão em Reais (R$). Foi feita a correlação de Spearman para nível socioeconômico dos pais, idade das adolescentes e seus pontos de vista. Os tipos de métodos e as perspectivas de adolescentes e pais foram analisados pelo teste χ2. Para determinar a concordância entre os pares e sua disposição a pagar, foi usado o gráfico de Bland-Altman.

Resultados

Foram coletadas 165 pesquisas. O método de curta duração foi significativamente mais aceitável para pagar que o de longa duração, por ambos pais e filhas. Os pais e suas filhas estavam dispostos a pagar, do próprio bolso, R$ 52,25±22,48 e R$ 51,63±21,24, pelo método contraceptivo reversível de curta duração, e R$ 176,83±130,34 e R$ 174,83±143,64, pelo de longa duração, respectivamente. A análise de Bland-Altman indicou concordância sobre ambas as perspectivas e o preço a que estavam dispostos a pagar por cada método anticoncepcional.

Conclusão

Pais e adolescentes estão mais dispostos a pagar pelos métodos reversíveis de curta duração. Houve concordância entre o pai e a filha para os valores pagos por cada método.

Contracepção reversível de longo prazo; Anticoncepção; Adolescente; Brasil

INTRODUCTION

Long-acting reversible contraception (LARC) methods do not rely on daily adherence, showing better effectiveness than short-acting reversible contraception (SARC) methods.(11. Allen S, Barlow E. Long-acting reversible contraception: an essential guide for pediatric primary care providers. Pediatr Clin North Am. 2017;64(2):359-69. Review.) However, there is relatively low uptake of these methods, partly due to their quite high initial cost.(22. Francis JK, Gold MA. Long-acting reversible contraception for adolescents: areview. JAMA Pediatr. 2017;171(7):694-701. Review.) Another obstacle is that LARC methods require procedures performed by healthcare professionals, and their provision may take longer. Also, there is a lack of information regarding these methods.(22. Francis JK, Gold MA. Long-acting reversible contraception for adolescents: areview. JAMA Pediatr. 2017;171(7):694-701. Review.)

In the United States, approximately 4.3% of adolescents using a contraceptive method choose LARC.(33. Kavanaugh ML, Jerman J, Finer LB. Changes in use of long-acting reversible contraceptive methods among U.S. women, 2009-2012. Obstet Gynecol. 2015;126(5):917-27.) A cross-sectional study performed in Brazil showed only 2.4% of entire cohort were using LARC and, interestingly, 58.7% of women who had never used the intrauterine device (IUD) would still not use it.(44. Borges AL, Araújo KS, Santos OA, Gonçalves RF, Fujimori E, Divino ED. Knowledge about the intrauterine device and interest in using it among women users of primary care services. Rev Lat Am Enfermagem. 2020;28:e3232.)

A nationwide survey taken in Sweden showed 11% of all contraception users reported they would use another method if they had the same price. An implant was the most desired contraceptive method among these women.(55. Kopp Kallner H, Thunell L, Brynhildsen J, Lindeberg M, Gemzell Danielsson K. Use of contraception and attitudes towards contraceptive use in Swedish women a nationwide survey. PLoS One. 2015;10(5):e0125990.) The CHOICE project showed the preferred choice of adolescents would be LARC methods over SARC, when some barriers were removed, such as lack of information, cost, and difficulty getting access.(66. Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception. 2011;84(5):493-8.) One study explored reducing cost barriers of LARC methods to increase the access and demonstrated increased LARC uptake.(77. Broecker J, Jurich J, Fuchs R. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis. Contraception. 2016;93(3):266-72.)

The use of LARC may have a potential role in reducing unintended pregnancies, because they are safe, effective, user-independent, and associated with high levels of user satisfaction.(66. Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception. 2011;84(5):493-8.)

We hypothesized the main problem of underuse of LARC is related to high up-front cost and lack of information. We also speculated parents would be more willing for their daughters to use LARC than the adolescents.

OBJECTIVE

To evaluate willingness of Brazilian female adolescent and their parents to pay for short- and long-acting reversible contraceptive methods, and their perspective on use of the methods.

METHODS

This is a cross-sectional survey with female adolescents aged 13 to 19 years, and one of their parents were required to answer a questionnaire built in platform Survey Monkey Inc® (San Mateo, California, USA) to be eligible for the study. Initially, the parents had to approve the daughter’s participation in the research. The data were analyzed in pairs (parent/daughter). All participants gave their written informed consent from before application of the questionnaire.

We presented an introductory movie to all participants before application of the questionnaire. The purpose of the movie was to present all contraceptive choices available in Brazil, and their pros and cons.

We performed data collection during April and June 2018, in São Paulo (SP), Brazil. The questionnaire collected data on the adolescent and their parent standpoints, separately. For each participant, we asked about acceptance of LARC and SARC, and their willingness to pay for both classes of contraceptive methods. The payment could be out-of-the-pocket or subsidized for both classes of contraception.

We included the following variables in the survey: age of the female adolescent, socioeconomic status of the family, willingness-to-pay for LARC and SARC methods. To assess willingness to pay, we first asked if they agreed to use one of the classes of contraception (LARC or SARC), by paying out-of-the-pocket; if affirmative, how much were they willing to pay for the method (Figure 1). If negative, we secondly asked about acceptance of the method, if it was subsidized. If affirmative, we asked how much they were willing to contribute to the method. If negative, we asked to state the reason for not accepting (Figure 1). These steps were performed for both classes of contraception, individually.

Figure 1
Survey flowchart

The currency to assess willingness to pay was Brazilian reals (R$). The conversion rate for US dollars (US$) for the year 2018 is US$ 1.00=R$ 3.6552.

To analyze the use of LARC and SARC between parent and daughter, we used the Fisher exact test. We employed the Spearman correlation for socioeconomic status and the parent’s willingness to pay, and the adolescent willingness to pay and their age using PAST version 3.25 software. We prepared the Bland-Altman graph to identify the agreement between the values of willingness to pay for both classes of contraceptive methods among parents and daughters. We conducted this analysis in pairs of parents and daughters, who had decided to pay any value for the contraceptive methods. We calculated descriptive statistics using mean±standard deviation.

We obtained ethical approval from the institutional review board of the Universidade Federal de São Paulo (UNIFESP), CAAE: 58281316.4.0000.5505, protocol 2.032.537.

RESULTS

A total of 174 questionnaires were answered, but nine parents did not authorize their daughters to answer. Therefore, we included a total of 165 questionnaires in this analysis. Most adolescent (67%) were aged 18 and 19 years, mean age of 17.6±1.4 years. During the survey, 55% of adolescents reported not using any contraceptive method. Among the adolescents that were using a contraceptive method, 81% stated that they were taking a birth control pill. Most participants (70%) had a monthly income of two to four minimum-wages.

More than 70% of both parents and daughters said they were aware of contraceptive methods (73% and 71%, respectively). Approximately 80% of survey participants responded adequately to the video questions, demonstrating a good understanding of the subject (79% for parents and 82% for adolescents).

The acceptance rate of LARC methods was 44% among parents (72 out of 165 parents) and 42% among adolescents (69 out of 165 adolescents) who were willing to pay out-of-pocket. Out of the remaining parents (56%) and adolescents (58%), 88% of parents would let their daughter use a LARC method, if it were subsidized, and 83% of adolescents would use if it were subsidized. The values expressed for willingness to pay are in table 1. The median willingness to pay for a LARC method was R$ 400,00, for both parents and daughters (Figure 2A).

Table 1
Willingness-to-pay values for parents and adolescents

Figure 2
Cumulative frequency of parents and adolescent willing to pay. A) Long-acting reversible contraception method; B) Short-acting reversible contraception method

Those parents who did not accept a LARC method, even if it were available for free, 12% indicated lack of information and uncertainties about safety of LARC methods as the reasons for their denial. The adolescents who alleged they would not use a LARC method, even if it were for free (17%), stated the main reasons would be lack of information, fear about the safety, and one adolescent declared she would not use due to the long time the device would be in place.

The acceptance rate of SARC methods was 79% among parents (131 out of 165 parents) and 76% among adolescents (126 out of 165 adolescents) that were willing to pay out-of-pocket. For the remaining parents (21%) and adolescents (24%), 76% of parents would let their daughter use a SARC method, if it were subsidized, and 81% of adolescents would use, if it were subsidized. The values expressed for willingness to pay are in table 1. The median willingness to pay for a SARC method was R$ 40,00 for both parents and daughters (Figure 2B).

Only eight parents (24%) said they would not allow their daughters to use a SARC method even for free, and the main reason was the daily use of hormonal contraceptives. Moreover, only seven girls (18%) said that they would not use a SARC method even if it were free. The main reasons were their dislike of hormonal contraception, the need for daily adherence, or simply not desiring to use a contraceptive method.

The acceptance of SARC, when compared to LARC methods, was preferred by parents and adolescents when paid out-of-pocket (pparents<0.0001 and padolescents<0.0001) (Figures 3A and 3B).

Figure 3
First acceptance of each class of contraceptive method (out-of-pocket). A) Parent standpoint; B) Daughter standpoint

However, the proportion of parents who did not allow contraception, under any circumstance, was not different between LARC and SARC methods (12% versus 24%, respectively; p=0.157). There was a weak correlation regarding the parents’ socioeconomic level and the value they would be willing to pay for both LARC and SARC methods (rs=0.382 and rs=0.326, respectively).

Likewise, the proportion of adolescents that stated would not use a contraception method under any circumstances, was not different between the LARC and SARC methods (17% versus 18%, respectively; p=0.857). There was no correlation regarding the adolescent age and the value expressed, both in LARC and SARC methods (rs=-0.128 and rs=-0.053, respectively).

We did not observe any difference in the uptake of LARC and SARC, between parents and the daughters, neither for out-of-pocket (pLARC=0.824 and pSARC=0.595) nor for subsidized (pLARC=0.410 and pSARC=0.576).

The Bland-Altman analysis comprised 147 pairs and 156 pairs for LARC and SARC, respectively. This analysis showed an agreement between parents and daughters for the values they were willing to pay (Figures 4A and 4B).

Figure 4

DISCUSSION

This study is the first to assess the willingness of adolescents and their parents to pay for contraception methods. We raised the hypothesis that, in Brazil, parents would be willing to pay more than their daughters for the contraceptive methods. We could not prove it, because counteracting our hypothesis, both adolescents and parents provided similar values of how much they were willing to pay. Moreover, parents and adolescents were more comfortable to accept out-of-pocket SARC rather than LARC methods. We were also able to show that a low percentage of both parents and adolescents would not use any form of contraception, even if it were available for free.

The use of contraception by young women is the best strategy to prevent unintended pregnancy and should be encouraged by governments as a public health policy. Several entities recommend using LARC as the best contraceptive choice for adolescents and young women, since they are safe and more efficient methods.(88. Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2012;120(4):983-8.

9. Fontenot HB, Fantasia HC. Long-acting reversible contraception for adolescents. Nurs Womens Health. 2015;19(3):253-9.

10. Lotke PS. Increasing use of long-acting reversible contraception to decrease unplanned pregnancy. Obstet Gynecol Clin North Am. 2015;42(4):557-67. Review.
-1111. Long-acting reversible contraception. London: National Institute for Health and Care Excellence (UK); 2019. (NICE Clinical Guidelines, No. 30).) However, there are still some issues and myths majorly regarding safety of these methods, creating barriers to disseminating them among adolescents. Our study showed the most cited reason for not using a LARC method was safety, and both parents and daughters mentioned it.

A survey conducted in the United States identified the patients’ most cited myths and misconceptions about LARC methods, including they caused menstrual irregularities, weight gain, increased risk of cancers, and ectopic pregnancy.(1212. Russo JA, Miller E, Gold MA. Myths and misconceptions about long-acting reversible contraception (LARC). J Adolesc Health. 2013;52(4 Suppl):S14-21. Review.,1313. Edwards AJ, DiVasta AD, Pitts S. Long-acting reversible contraception side effect management. Curr Opin Pediatr. 2020;32(4):461-70. Review.) Regarding IUD only, the list is long, including abortions, pelvic inflammatory disease, infertility, and too big to be placed in nulliparous women.(1212. Russo JA, Miller E, Gold MA. Myths and misconceptions about long-acting reversible contraception (LARC). J Adolesc Health. 2013;52(4 Suppl):S14-21. Review.) We speculate these misconceptions and myths are raised by their next of kin, and this hypothesis may be sustained by the agreement between parents and their daughters regarding the value they would pay for both methods. Hence, we agree with numerous specialists that education is a key factor to be extensively approached by health care professionals, to promote a more valuable and better choice for adolescents.(22. Francis JK, Gold MA. Long-acting reversible contraception for adolescents: areview. JAMA Pediatr. 2017;171(7):694-701. Review.,1414. Sherin M, Waters J. Long-acting reversible contraceptives for adolescent females: a review of current best practices. Curr Opin Pediatr. 2019;31(5): 675-82. Review.)

Our study showed the acceptance of SARC methods by both parents and daughters is higher than LARC methods, when the decision is to pay out-of-pocket. Indeed, a study conducted in Spain also showed that young women, aged up to 29 years, preferred to use SARC methods, such as combined oral contraceptive, vaginal ring, and male condom, for contraception.(1515. Parra Ribes I, Rascón Poza JJ, Pérez Campos E, Bugella Yudice I, Rodríguez Domingo MJ. Economic burden of contraception management in Spain. J Health Econ Outcomes Res. 2018;6(1):63-74.) This result highlights the importance of broader education and easier access to LARC methods to the population, especially young women, to prevent unintended pregnancies.

The main reason adolescents did not desire the SARC method was the daily hormonal dose and the consequent safety issue of increasing the risk of thrombosis. Indeed, combined oral contraceptives, popularly known as birth control pills, may cause thrombosis. However, some studies alert some other risk factors that further increase this risk, such as obesity, smoking habit, and family history.(1616. McDaid A, Logette E, Buchillier V, Muriset M, Suchon P, Pache TD, et al. Risk prediction of developing venous thrombosis in combined oral contraceptive users. PLoS One. 2017;12(7):e0182041.) One study conducted in Japan identified that this risk is more likely to occur in women aged over 40 years.(1717. Sugiura K, Ojima T, Urano T, Kobayashi T. The incidence and prognosis of thromboembolism associated with oral contraceptives: age-dependent difference in Japanese population. J Obstet Gynaecol Res. 2018;44(9): 1766-72.)

Our study has some limitations. First, this is a pilot study focusing on the Brazilian population’s willingness to pay for contraceptive methods used by adolescents; therefore, it has no statistical power. Second, since the Brazilian Public Health System (SUS - Sistema Único de Saúde) only supplies the copper IUD as LARC, there is scarce knowledge about such method. Nonetheless, we have presented an introductory movie about all contraceptive methods. Third, we did not obtain a correlation between the socioeconomic status and the value the participants were willing to pay for the methods, due to the lack of representativeness of the different socioeconomic brackets. Most participants were from the lower socioeconomic brackets. Fourth, we employed the questionnaire simultaneously for parents and daughters; this approach may have limited the number of adolescent respondents and influenced their decision.

An educational approach for both adolescents and parents about the contraceptive options is of utmost importance for the former, especially at the beginning of their sexual life. Implementing programs and campaigns to raise awareness on sexual and family planning to these populations are primordial, along with a more comprehensive availability of LARC methods. These actions can decrease unintended pregnancy in adolescents, and reduce health and social consequences, such as maternal death, prematurity, childhood morbidity, and school dropouts.

CONCLUSION

A higher percentage of parents and their daughters showed a greater acceptance of short-acting reversible contraception methods, when asked to pay out-of-pocket, as compared to long-acting reversible contraceptive methods. A low percentage of participants would not use at all any form of contraception. The values they were willing to pay for long-acting or short-acting reversible contraception methods did not correlate with socioeconomic status or adolescent age. We found an agreement for the value parents and daughters were willing to pay for long- and short-acting reversible contraceptive methods.

ACKNOWLEDGEMENT

To all collaborators for their support in carrying out this study, and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) for the educational grant to develop this work. To Gianni dos Santos, MSc., for assisting in the statistical analysis.

This work was supported by from CAPES. The financing supporter played no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.

REFERENCES

  • 1
    Allen S, Barlow E. Long-acting reversible contraception: an essential guide for pediatric primary care providers. Pediatr Clin North Am. 2017;64(2):359-69. Review.
  • 2
    Francis JK, Gold MA. Long-acting reversible contraception for adolescents: areview. JAMA Pediatr. 2017;171(7):694-701. Review.
  • 3
    Kavanaugh ML, Jerman J, Finer LB. Changes in use of long-acting reversible contraceptive methods among U.S. women, 2009-2012. Obstet Gynecol. 2015;126(5):917-27.
  • 4
    Borges AL, Araújo KS, Santos OA, Gonçalves RF, Fujimori E, Divino ED. Knowledge about the intrauterine device and interest in using it among women users of primary care services. Rev Lat Am Enfermagem. 2020;28:e3232.
  • 5
    Kopp Kallner H, Thunell L, Brynhildsen J, Lindeberg M, Gemzell Danielsson K. Use of contraception and attitudes towards contraceptive use in Swedish women a nationwide survey. PLoS One. 2015;10(5):e0125990.
  • 6
    Mestad R, Secura G, Allsworth JE, Madden T, Zhao Q, Peipert JF. Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project. Contraception. 2011;84(5):493-8.
  • 7
    Broecker J, Jurich J, Fuchs R. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis. Contraception. 2016;93(3):266-72.
  • 8
    Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2012;120(4):983-8.
  • 9
    Fontenot HB, Fantasia HC. Long-acting reversible contraception for adolescents. Nurs Womens Health. 2015;19(3):253-9.
  • 10
    Lotke PS. Increasing use of long-acting reversible contraception to decrease unplanned pregnancy. Obstet Gynecol Clin North Am. 2015;42(4):557-67. Review.
  • 11
    Long-acting reversible contraception. London: National Institute for Health and Care Excellence (UK); 2019. (NICE Clinical Guidelines, No. 30).
  • 12
    Russo JA, Miller E, Gold MA. Myths and misconceptions about long-acting reversible contraception (LARC). J Adolesc Health. 2013;52(4 Suppl):S14-21. Review.
  • 13
    Edwards AJ, DiVasta AD, Pitts S. Long-acting reversible contraception side effect management. Curr Opin Pediatr. 2020;32(4):461-70. Review.
  • 14
    Sherin M, Waters J. Long-acting reversible contraceptives for adolescent females: a review of current best practices. Curr Opin Pediatr. 2019;31(5): 675-82. Review.
  • 15
    Parra Ribes I, Rascón Poza JJ, Pérez Campos E, Bugella Yudice I, Rodríguez Domingo MJ. Economic burden of contraception management in Spain. J Health Econ Outcomes Res. 2018;6(1):63-74.
  • 16
    McDaid A, Logette E, Buchillier V, Muriset M, Suchon P, Pache TD, et al. Risk prediction of developing venous thrombosis in combined oral contraceptive users. PLoS One. 2017;12(7):e0182041.
  • 17
    Sugiura K, Ojima T, Urano T, Kobayashi T. The incidence and prognosis of thromboembolism associated with oral contraceptives: age-dependent difference in Japanese population. J Obstet Gynaecol Res. 2018;44(9): 1766-72.

Publication Dates

  • Publication in this collection
    11 Oct 2021
  • Date of issue
    2021

History

  • Received
    9 Dec 2020
  • Accepted
    26 Mar 2021
Instituto Israelita de Ensino e Pesquisa Albert Einstein Avenida Albert Einstein, 627/701 , 05651-901 São Paulo - SP, Tel.: (55 11) 2151 0904 - São Paulo - SP - Brazil
E-mail: revista@einstein.br